[Breaking] Lemon Healthcare Hits Upper Limit on Second Day of KOSDAQ Listing... Successful Sharp Rebound
Lemon Healthcare, newly listed on the KOSDAQ market, surged to the upper limit on the afternoon of the 7th, its second day of trading, showing a strong rebound.
![[Breaking] Lemon Healthcare Hits Upper Limit on Second Day of KOSDAQ Listing... Successful Sharp Rebound](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/581911/a630da1c47d6049c/variants/hero.webp)
Lemon Healthcare, newly listed on the KOSDAQ market, surged to the upper limit on the afternoon of the 7th, its second day of trading, showing a strong rebound.
As of 12:53 p.m. on the 7th, Lemon Healthcare was trading at 12,220 won, up 2,820 won (30.00%) from the previous trading day, rising to the daily price limit.
Previously, Lemon Healthcare made its debut on the KOSDAQ market on the 6th with its public offering price set at 10,000 won. However, on its first day of trading, it closed down 6%, falling below the offering price and recording a somewhat disappointing first-day performance.
However, after successfully rebounding from the early hours of trading on the 7th, buying pressure intensified heading into the afternoon, ultimately pushing the stock to the upper limit.
Meanwhile, market investors are closely watching future trading volume, supply and demand changes, and whether the public offering price will stabilize, taking into account the characteristic high volatility of newly listed stocks.
[※ Investment decisions are the sole responsibility of the investor, and this article is not intended to solicit investment.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] KOSPI Plunges 8%, Triggering Level 1 Circuit Breaker... Trading Halted for 20 Minutes](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/581295/f96ea0d6ae6103cc/variants/hero.webp)
![[Upcoming IPO] Ingenia Therapeutics Subscription Open July 30–31… LCIDEC Bispecific Antibody Platform and Vascular Disease New Drug in Focus](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/582901/0862e907e2395e27/variants/hero.webp)
![[Breaking] Jusung Engineering Triggers VI Twice During Session... Turns Lower to 170,000-Won Range After Early Surge](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/581031/0c2a8f5a6d5bef88/variants/hero.webp)